The Relative Strength Index (RSI) is a technical indicator used in financial markets to measure the speed and change of price movements. It ranges from 0 to 100 and is typically used to assess whether a stock or asset is overbought or oversold.

An RSI value above 70 indicates that the asset might be overbought, suggesting it could be overvalued and might experience a price correction. Conversely, an RSI below 30 indicates that the asset might be oversold, potentially signaling that it is likely undervalued and could experience a price rebound.

The stocks to watch out for are listed below 

Chambal Fertilisers & Chemicals Ltd

Chambal Fertilisers & Chemicals Ltd, part of the KK Birla Group, is one of India’s largest private sector fertilizer producers, headquartered in Kota, Rajasthan. Chambal also markets a range of other agri-inputs and has a strong presence in northern and central India, supporting farmers with advisory services and sustainable farming initiatives.

With a market capitalization of Rs. 22,296.30 crores on Monday, the stock closed at Rs. 556.50, with an RSI of 27.90, indicating that it is in the oversold zone, offering the potential for an upside bounce.

Gujarat Fluorochemicals Ltd

Gujarat Fluorochemicals Ltd is a leading chemical manufacturing company in India, specializing in the production of fluoropolymers, refrigerants, and specialty chemicals. The company is known for its advanced technology and exports its products, serving industries such as automotive, electronics, chemicals, and pharmaceuticals.

With a market capitalization of Rs. 39,281.81 crores on Monday, the stock closed at Rs. 3575.95, with an RSI of 28.18, indicating that it is in the oversold zone, offering the potential for an upside bounce.

Dr Agarwals Health Care Ltd

Dr Agarwals Health Care Ltd is a prominent eye care chain in India, offering comprehensive ophthalmology services through its network of hospitals and clinics, and the group is known for its advanced eye surgeries, treatments, and research, serving millions of patients across India and abroad. 

With a market capitalization of Rs. 10,545.46 crores on Monday, the stock closed at Rs. 333.55, with an RSI of 26.98, indicating that it is in the oversold zone, offering the potential for an upside bounce.

Written by Sridhar J 

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or t

×